H. pylori

Reveal HP detects HP antibodies in serum, plasma or whole blood produced in response to HP infection.  

Helicobacter pylori (HP) is a bacterial agent associated with peptic ulcer disease and cancers of the human gastrointestinal tract.  HP infections, prevalent throughout the world, are treatable with antibiotics; however untreated HP infections can lead to stomach cancer.   

This product is not cleared by the FDA, and therefore is not available for sale or use in the USA.

For the MedMira Rapid H. Pylori Antibody Test, which is cleared by the FDA for use in the USA, click here.

Reveal HP

Reveal HP can deliver highly accurate results to patients and their healthcare providers within minutes, enabling the right treatment to begin immediately. Reveal HP detects HP antibodies in serum, plasma or whole blood produced in response to HP infection. The presence of HP antibodies is indicative of exposure to the agent, and assists in the confirmation of HP infection with additional tests.

 

Reveal HP is available in three product formats as follows:

Cat. No. 815311004148
(Point-of-Care)
Qty. 20 tests per box
This format is ideally suited to testing at the point of patient care, settings such as mobile clinics requiring a portable and all-in-one testing solution.

Cat. No. 815311004155
(LAB+)
Qty. 50 tests per box
This format maximizes customer flexibility in for testing serum, plasma, and whole blood specimens.

Cat. No. 815311004162
(LAB S/P)
Qty. 50 tests per box
This format is ideally suited for laboratories using serum and plasma specimens, and batch testing.